Relx PLC ADR (RELX), formerly Reed Elsevier Group, is an information and analytics technology firm based in the UK. Its three primary business segments include Science & Technology, Health & Medical, Risk & Business Analytics. These domains cater to the needs of professionals across sectors, specialising in digital and print publishing, risk management tools, decision tools, and analytics.
Relx operates internationally, with a significant presence in North America, Europe and Asia. Its business segment, Science & Technology, provides reliable information and analytics to scientists and engineers enabling effective research outcomes. With a deep understanding of the scientific community’s requirements, Relx caters to millions of users globally, enhancing scientific discovery and innovation.
Its Health and Medical segment supports healthcare professionals, research scholars, and students by providing advanced clinical decision tools, research platforms, e-learning, and scientific, technical and medical (STM) information tools.
The Risk & Business Analytics division is responsible for providing high-end data services, analytics, and decision tools to major financial institutions, insurers, multinational companies, governments, and institutions. Its solutions aid customers in handling different aspects of risk, improve their operations and profitability, and accomplish regulatory compliance effectively.
Relx PLC ADR prides itself on the consistent investment in technology to achieve outstanding customer experience. Its rigorous data analysis and real-world experience have led the innovation in the information and analytic industry. RELX has been recognized for its contribution to the high-quality information provided to the industries it serves.
The company is listed under the ticker symbol "RELX" on several stock exchanges, including the London and Amsterdam stock exchanges, as well as the New York Stock Exchange in the United States for its ADR (American Depositary Receipt).
Despite the impact of the pandemic, in 2020, Relx proved resilience by delivering stable revenue growth, showcasing the robustness of its business model. This global multinational has solid-enviable credentials and is well-positioned for future growth, based on its continued commitment to innovation, investment in technology, and impressive scope of operations.
In summary, Relx PLC ADR is a globally recognized information and analytics provider, providing pivotal and impactful services for a range of sectors. This customer-focused organization boasts of resilience, adaptability, and remarkable growth, making it an influential player in the tech and analytics industries.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Relx Plc (NYSE:RELX) has received a "Moderate Buy" consensus rating from Wall Street brokerages, with five analysts recommending a buy, three a hold, and one a strong-buy. Despite the positive analyst sentiment, the company recently reduced its dividend to $0.2785 per share from $0.6559. Institutional investors and hedge funds collectively own 15.02% of the technology company, which specializes in information and analytics.
Wall Street Zen downgraded Relx (NYSE:RELX) from a "buy" to a "hold" rating, though the overall analyst consensus remains a "Moderate Buy" for the information and analytics company. Despite the downgrade, institutional investors like Capital International Investors and Morgan Stanley have increased their holdings in RELX. The stock opened at $33.76, down 0.2%, and has a 12-month trading range of $27.57 to $48.40.
RELX PLC has announced an additional share buyback program of £125 million, running from September 7, 2026, to October 21, 2026. This follows a recently completed £150 million buyback and is part of a larger £2.25 billion allocation for share repurchases in 2026. The repurchased shares will be held in treasury, aiming to reduce the company's capital base.
RELX PLC has initiated a new GBP125 million share buyback program, running until October 21, as part of its larger plan to return GBP2.25 billion to shareholders in 2026. This follows the completion of a previous GBP125 million buyback, with all repurchased shares to be held in treasury. The London-based information and analytics provider saw its stock price down 2.0% on Monday morning, with a 26% decrease over the past 12 months.
Wall Street Zen has upgraded Relx (NYSE:RELX) from a "hold" to a "buy" rating, aligning with a "Moderate Buy" consensus from other analysts like Barclays and Goldman Sachs. The company's shares opened at $35.50, trading above key moving averages, and institutional investors have increased their holdings, collectively owning over 15% of the stock. Relx provides information, analytics, and decision tools across various sectors, including scientific, legal, risk, and business analytics.
RELX PLC shares fell by 2.06% on Friday, closing at £26.20, underperforming a steady FTSE 100 Index. The company's stock is now 26.71% below its 52-week high of £35.75, which was reached on September 18th.
Relx Plc (NYSE:RELX) has received an average "Moderate Buy" recommendation from eight brokerages, with four analysts suggesting a buy, three a hold, and one a strong buy. Recent analyst actions include new buy ratings from Goldman Sachs and Barclays, contrasted with downgrades from Morgan Stanley and Wall Street Zen. The company's stock opened at $36.50, with institutional investors owning 15.02% of its shares, and has recently declared a dividend of $0.2785 per share.